Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cleft upper lip
|
282 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.040 | 0.750 | 4 | 1998 | 2019 | ||||
early pregnancy
|
8 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.040 | 1.000 | 4 | 1998 | 2018 | ||||
Spina Bifida Cystica
|
5 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.040 | 0.750 | 4 | 1998 | 2004 | ||||
Psychotic Disorders
|
179 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.020 | 1.000 | 2 | 1998 | 2006 | ||||
Cystathionine beta-Synthase Deficiency Disease
|
118 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||
Hypercholesterolemia, Familial
|
1423 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||
Hyperlipoproteinemia Type IIa
|
661 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||
Colorectal Carcinoma
|
1962 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.829 | 70 | 1999 | 2018 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.839 | 56 | 1999 | 2018 | ||||
Ischemic stroke
|
704 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.923 | 52 | 1999 | 2019 | ||||
Schizophrenia
|
2897 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.841 | 44 | 1999 | 2019 | ||||
Down Syndrome
|
80 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.882 | 34 | 1999 | 2019 | ||||
Complete Trisomy 21 Syndrome
|
77 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.879 | 33 | 1999 | 2019 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.938 | 32 | 1999 | 2019 | ||||
Thrombophilia
|
43 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.938 | 32 | 1999 | 2019 | ||||
Vascular Diseases
|
40 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 1.000 | 24 | 1999 | 2018 | ||||
Methylenetetrahydrofolate reductase polymorphism
|
7 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.864 | 22 | 1999 | 2018 | ||||
Folic Acid Deficiency
|
8 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.941 | 17 | 1999 | 2017 | ||||
Congenital Abnormality
|
73 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 1.000 | 14 | 1999 | 2019 | ||||
Methylenetetrahydrofolate reductase gene mutation
|
3 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 1.000 | 14 | 1999 | 2009 | ||||
Miscarriage
|
56 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.923 | 13 | 1999 | 2019 | ||||
Kidney Failure, Chronic
|
425 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.833 | 12 | 1999 | 2014 | ||||
Chronic kidney disease stage 5
|
194 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.100 | 0.800 | 10 | 1999 | 2014 | ||||
Epilepsy
|
339 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.070 | 0.857 | 7 | 1999 | 2018 | ||||
Kidney Diseases
|
140 | 0.330 | 0.920 | 1 | 11796309 | missense variant | A/G | snv | 4.0E-06 | 7.0E-06 | 0.060 | 0.667 | 6 | 1999 | 2012 |